These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 9667976)

  • 1. beta-Lactam derivatives as inhibitors of human cytomegalovirus protease.
    Yoakim C; Ogilvie WW; Cameron DR; Chabot C; Guse I; Haché B; Naud J; O'Meara JA; Plante R; Déziel R
    J Med Chem; 1998 Jul; 41(15):2882-91. PubMed ID: 9667976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potent beta-lactam inhibitors of human cytomegalovirus protease.
    Yoakim C; Ogilvie WW; Cameron DR; Chabot C; Grand-Maître C; Guse I; Haché B; Kawai S; Naud J; O'Meara JA; Plante R; Déziel R
    Antivir Chem Chemother; 1998 Sep; 9(5):379-87. PubMed ID: 9875391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design and synthesis of pyrrolidine-5,5'-trans-lactams (5-oxo-hexahydropyrrolo[3,2-b]pyrroles) as novel mechanism-based inhibitors of human cytomegalovirus protease. 4. Antiviral activity and plasma stability.
    Borthwick AD; Davies DE; Ertl PF; Exall AM; Haley TM; Hart GJ; Jackson DL; Parry NR; Patikis A; Trivedi N; Weingarten GG; Woolven JM
    J Med Chem; 2003 Oct; 46(21):4428-49. PubMed ID: 14521407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design of translactam HCMV protease inhibitors as potent antivirals.
    Borthwick AD
    Med Res Rev; 2005 Jul; 25(4):427-52. PubMed ID: 15789440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. From 1-acyl-beta-lactam human cytomegalovirus protease inhibitors to 1-benzyloxycarbonylazetidines with improved antiviral activity. A straightforward approach to convert covalent to noncovalent inhibitors.
    Gerona-Navarro G; Pérez de Vega MJ; García-López MT; Andrei G; Snoeck R; De Clercq E; Balzarini J; González-Muñiz R
    J Med Chem; 2005 Apr; 48(7):2612-21. PubMed ID: 15801851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of novel, potent and bioavailable proline-urea based macrocyclic HCV NS3/4A protease inhibitors.
    Vendeville S; Nilsson M; de Kock H; Lin TI; Antonov D; Classon B; Ayesa S; Ivanov V; Johansson PO; Kahnberg P; Eneroth A; Wikstrom K; Vrang L; Edlund M; Lindström S; Van de Vreken W; McGowan D; Tahri A; Hu L; Lenz O; Delouvroy F; Van Dooren M; Kindermans N; Surleraux D; Wigerinck P; Rosenquist A; Samuelsson B; Simmen K; Raboisson P
    Bioorg Med Chem Lett; 2008 Dec; 18(23):6189-93. PubMed ID: 18954982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peptidomimetic inhibitors of the human cytomegalovirus protease.
    Ogilvie W; Bailey M; Poupart MA; Abraham A; Bhavsar A; Bonneau P; Bordeleau J; Bousquet Y; Chabot C; Duceppe JS; Fazal G; Goulet S; Grand-Maître C; Guse I; Halmos T; Lavallée P; Leach M; Malenfant E; O'Meara J; Plante R; Plouffe C; Poirier M; Soucy F; Yoakim C; Déziel R
    J Med Chem; 1997 Dec; 40(25):4113-35. PubMed ID: 9406601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The herpesvirus protease: mechanistic studies and discovery of inhibitors of the human cytomegalovirus protease.
    Flynn DL; Becker DP; Dilworth VM; Highkin MK; Hippenmeyer PJ; Houseman KA; Levine LM; Li M; Moormann AE; Rankin A; Toth MV; Villamil CI; Wittwer AJ; Holwerda BC
    Drug Des Discov; 1997 May; 15(1):3-15. PubMed ID: 9332827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 4"-Benzoylureido-TSAO derivatives as potent and selective non-nucleoside HCMV inhibitors. Structure-activity relationship and mechanism of antiviral action.
    de Castro S; Peromingo MT; Naesens L; Andrei G; Snoeck R; Balzarini J; Velázquez S; Camarasa MJ
    J Med Chem; 2008 Sep; 51(18):5823-32. PubMed ID: 18707089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and anti-HCMV activity of 1-acyl-beta-lactams and 1-acylazetidines derived from phenylalanine.
    Gerona-Navarro G; Pérez de Vega MJ; García-López MT; Andrei G; Snoeck R; Balzarini J; De Clercq E; González-Muñiz R
    Bioorg Med Chem Lett; 2004 May; 14(9):2253-6. PubMed ID: 15081019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxyanion-mediated inhibition of serine proteases.
    Presnell SR; Patil GS; Mura C; Jude KM; Conley JM; Bertrand JA; Kam CM; Powers JC; Williams LD
    Biochemistry; 1998 Dec; 37(48):17068-81. PubMed ID: 9836602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of substrate analogue inhibitors for the human airway trypsin-like protease HAT.
    Sielaff F; Böttcher-Friebertshäuser E; Meyer D; Saupe SM; Volk IM; Garten W; Steinmetzer T
    Bioorg Med Chem Lett; 2011 Aug; 21(16):4860-4. PubMed ID: 21741839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficient synthesis of an enantiopure beta-lactam as an advanced precursor of thrombin and tryptase inhibitors.
    Annunziata R; Benaglia M; Cinquini M; Cozzi F; Maggioni F; Puglisi A
    J Org Chem; 2003 Apr; 68(7):2952-5. PubMed ID: 12662075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relationship between inhibitors of eukaryotic and prokaryotic serine proteases.
    Konaklieva MI; Plotkin BJ
    Mini Rev Med Chem; 2004 Sep; 4(7):721-39. PubMed ID: 15379640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potent inhibitors of the hepatitis C virus NS3 protease: use of a novel P2 cyclopentane-derived template.
    Johansson PO; Bäck M; Kvarnström I; Jansson K; Vrang L; Hamelink E; Hallberg A; Rosenquist A; Samuelsson B
    Bioorg Med Chem; 2006 Aug; 14(15):5136-51. PubMed ID: 16675222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and antiviral activity of monobactams inhibiting the human cytomegalovirus protease.
    Ogilvie WW; Yoakim C; Dô F; Haché B; Lagacé L; Naud J; O'Meara JA; Déziel R
    Bioorg Med Chem; 1999 Aug; 7(8):1521-31. PubMed ID: 10482444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 4-Benzyloxy-gamma-sultone derivatives: discovery of a novel family of non-nucleoside inhibitors of human cytomegalovirus and varicella zoster virus.
    De Castro S; García-Aparicio C; Andrei G; Snoeck R; Balzarini J; Camarasa MJ; Velázquez S
    J Med Chem; 2009 Mar; 52(6):1582-91. PubMed ID: 19226140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and evaluation of 4-substituted benzylamine derivatives as beta-tryptase inhibitors.
    Miyazaki Y; Kato Y; Manabe T; Shimada H; Mizuno M; Egusa T; Ohkouchi M; Shiromizu I; Matsusue T; Yamamoto I
    Bioorg Med Chem Lett; 2006 Jun; 16(11):2986-90. PubMed ID: 16540315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peptide-β-lactam Inhibitors of Dengue and West Nile Virus NS2B-NS3 Protease Display Two Distinct Binding Modes.
    Dražić T; Kopf S; Corridan J; Leuthold MM; Bertoša B; Klein CD
    J Med Chem; 2020 Jan; 63(1):140-156. PubMed ID: 31804823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigation of the covalent modification of the catalytic triad of human cytomegalovirus protease by pseudo-reversible beta-lactam inhibitors and a peptide chloromethylketone.
    Haley TM; Angier SJ; Borthwick AD; Montgomery DS; Purvis IJ; Smart DH; Bessant C; Van Wely C; Hart GJ
    J Mass Spectrom; 1998 Dec; 33(12):1246-55. PubMed ID: 9875526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.